PSEN1 and Alzheimer disease: Our data revealed that APP/PS1-PAMAGPR120+/+ mice had median life expectancy (MLE) of 721 days, compared to 812 days for C57BL/6-PAMAGPR120+/+ mice (Fig. 7h,i), showing that AD mice had shorter lifespan than non-AD control mice.